Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Kane Biotech Inc V.KNE

Alternate Symbol(s):  KNBIF

Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (68 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired from research institutions. DispersinB, Aledex, coactiv+, coactiv+, DermaKB, DermaKB Biofilm, and revyve are trademarks of the Company. Its patented coactiv+ technology is specifically formulated to destabilize biofilm and create an environment for fast wound healing. In Wound Care & Surgical applications, in addition to revyve Antimicrobial Wound Gel, it is developing follow-on products with three applications: coactiv+ Antimicrobial Surgical Hydrogel, coactiv+ Antimicrobial Wound Gel Spray, and coactiv+ Antimicrobial Wound Rinse. The Company's other biofilm disruption technology is DispersinB.


TSXV:KNE - Post by User

Bullboard Posts
Comment by siboon Jul 07, 2011 8:31pm
228 Views
Post# 18808834

Enough Already

Enough Already
Let's be fair here.  Some love Kane for its potential.  Some, including me, are a little more cautious.

Before levelling charges of pump and dump recognize that enthusiasm is not a disease, rather a conviction, and that markets have a tempo of their own.  There are many, many buyers who are willing to make stocks cheap before they buy and have the tools to do so.  There are also many people who make a living by simply shorting stocks that have quickly risen.

None of us know Kane's future for sure.  Make your bet and live with it but don't slander opposing views.

Kane looks good but clearly has to pass regulatory hurdles, find market acceptance and compete with alternatives. A dose of hydrogen peroxide or, a silver salt, may work as well.  Or, it may not. Test, trials and experiences will ultimately prove it good or indifferent.

Market fluctuations do not define science. Ultimately, science and experience will determine the worth of your investment.
Bullboard Posts